Skip to main content
. Author manuscript; available in PMC: 2014 Nov 12.
Published in final edited form as: Leuk Res. 2009 Jul 30;34(3):344–351. doi: 10.1016/j.leukres.2009.06.035

Figure 1.

Figure 1

The isoprenoid biosynthetic pathway (IBP) and pharmacological inhibitors. Substrates and products of the pathway are shown in black, enzymes are shown in blue, and specific inhibitors are shown in red.